{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"100","value":"95"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"}],"units":"Participants"}],"description":"Occurrence of genetically distinct cell types in a single organism","dispersionType":"Full Range","groups":[{"description":"Day -7: Rituximab 375 mg/m2 Day -6: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -5: Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -4: Clofarabine 30 mg/m2 IV over 1 hour and Antithymocyte globulin (Thymoglobulin) 3 mg/kg IV over 4 hours Day -3: Clofarabine 30 mg/m2 IV over 1 hour Day -2: Clofarabine 30 mg/m2 IV over 1 hour Day -1: Rest Day 0: Stem Cell Infusion","id":"OG000","title":"Conditioning for Graft Failure After Transplant"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Day 28 post transplantation","title":"Chimerism","type":"SECONDARY","unitOfMeasure":"percentage of donor cells"}